男性髋关节表面置换术:至少15年随访研究
该回顾性研究纳入2006年1月至2008年12月间407例男性患者的472例连续髋关节表面置换术(HRA),平均随访16.0年(范围15.0至18.4年)。15年总体生存率为95.1%,股骨头尺寸≥48 mm者生存率95.8%,<48 mm者91.3%;未翻修髋关节最终随访功能评分良好,中位血清铬2.3 μg/L、钴1.7 μg/L,共26例翻修,无菌性松动最常见(n=11)。作者认为HRA对适当选择的男性患者是可行的长期解决方案。
要点
- 15年总体生存率95.1%,股骨头尺寸≥48 mm者95.8%,<48 mm者91.3%。
- 未翻修髋关节最终随访改良Harris髋关节评分97.3±6.4,髋关节残疾与骨关节炎结局评分-关节置换97.8±5.6。
- 共26例翻修,无菌性松动最常见(n=11)。
核心结论
- 作者认为HRA对适当选择的男性患者是可行的长期解决方案,在至少15年随访时具有高生存率和良好功能结局。
研究设计与样本
- 回顾性研究,纳入2006年1月至2008年12月间407例男性患者的472例连续HRA,至少随访15年,平均随访16.0年(范围15.0至18.4年)。
- 收集患者报告结局指标(改良Harris髋关节评分、髋关节残疾与骨关节炎结局评分-关节置换、疼痛视觉模拟评分、加州大学洛杉矶分校活动量表)、血清金属离子水平、生存率和影像学结局,采用Kaplan-Meier生存分析评估假体生存率。
主要发现
- 15年总体生存率为95.1%。
- 股骨头尺寸≥48 mm的假体生存率为95.8%,<48 mm者为91.3%。
- 未翻修髋关节最终随访时,髋关节残疾与骨关节炎结局评分-关节置换为97.8±5.6,改良Harris髋关节评分为97.3±6.4,疼痛视觉模拟评分为0.4±1.1,加州大学洛杉矶分校活动量表为8.0±1.9。
- 最终随访时中位血清铬水平为2.3 μg/L,中位血清钴水平为1.7 μg/L。
- 共发生26例翻修,无菌性松动为最常见原因(n=11)。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Hip resurfacing arthroplasty (HRA) has emerged as an alternative to total hip arthroplasty for managing osteoarthritis, particularly in younger, active men. However, long-term data on HRA outcomes in the United States remains limited. METHODS: We retrospectively examined 472 consecutive HRA cases in 407 men performed between January 2006 and December 2008 with minimum 15-year follow-up outcomes. Patient-reported outcome measures, including the modified Harris Hip Score, Hip Disability and Osteoarthritis Outcome Score for Joint Replacement, Visual Analog Scale for pain, and University of California-Los Angeles Activity Scale, were collected. Serum metal ion levels, survivorship, and radiographic outcomes were also assessed. Kaplan-Meier survival analysis was performed to evaluate implant survivorship. The mean follow-up was 16.0 years (range, 15.0 to 18.4). RESULTS: The overall survivorship at 15 years was 95.1%. Implants with femoral head sizes ≥ 48 mm demonstrated 95.8% survivorship, while those < 48 mm showed 91.3% survivorship. For unrevised hips, mean final follow-up scores were Hip Disability and Osteoarthritis Outcome Score for Joint Replacement 97.8 ± 5.6, modified Harris Hip Score 97.3 ± 6.4, Visual Analog Scale 0.4 ± 1.1, and University of California-Los Angeles Activity 8.0 ± 1.9. The median serum metal ion levels at the final follow-up were 2.3 μg/L for chromium and 1.7 μg/L for cobalt. There were 26 revisions that occurred, with aseptic loosening being the most common cause (n = 11). CONCLUSIONS: This study demonstrates that HRA is a viable long-term solution for appropriately selected men with high survivorship and positive functional outcomes at a minimum 15-year follow-up.
引用
- Saluja A, Wong Z, Jordan LA, et al. Hip Resurfacing Arthroplasty in Men: A Minimum 15-Year Follow-Up Study. J Arthroplasty. 2025. PMID: 40120657. doi:10.1016/j.arth.2025.03.038
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。